These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36987747)

  • 1. 2B-Alert App 2.0: personalized caffeine recommendations for optimal alertness.
    Vital-Lopez FG; Doty TJ; Anlap I; Killgore WDS; Reifman J
    Sleep; 2023 Jul; 46(7):. PubMed ID: 36987747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2B-Alert App: A mobile application for real-time individualized prediction of alertness.
    Reifman J; Ramakrishnan S; Liu J; Kapela A; Doty TJ; Balkin TJ; Kumar K; Khitrov MY
    J Sleep Res; 2019 Apr; 28(2):e12725. PubMed ID: 30033688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2B-Alert Web 2.0, an Open-Access Tool for Predicting Alertness and Optimizing the Benefits of Caffeine: Utility Study.
    Reifman J; Kumar K; Hartman L; Frock A; Doty TJ; Balkin TJ; Ramakrishnan S; Vital-Lopez FG
    J Med Internet Res; 2022 Jan; 24(1):e29595. PubMed ID: 35084336
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Reifman J; Kumar K; Wesensten NJ; Tountas NA; Balkin TJ; Ramakrishnan S
    Sleep; 2016 Dec; 39(12):2157-2159. PubMed ID: 27634801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Vigilant Attention and Cognitive Performance Using Self-Reported Alertness, Circadian Phase, Hours since Awakening, and Accumulated Sleep Loss.
    Bermudez EB; Klerman EB; Czeisler CA; Cohen DA; Wyatt JK; Phillips AJ
    PLoS One; 2016; 11(3):e0151770. PubMed ID: 27019198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine dosing strategies to optimize alertness during sleep loss.
    Vital-Lopez FG; Ramakrishnan S; Doty TJ; Balkin TJ; Reifman J
    J Sleep Res; 2018 Oct; 27(5):e12711. PubMed ID: 29808510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When to sleep and consume caffeine to boost alertness.
    Vital-Lopez FG; Doty TJ; Reifman J
    Sleep; 2024 Oct; 47(10):. PubMed ID: 38877981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of sleep-2-Peak: A smartphone application that can detect fatigue-related changes in reaction times during sleep deprivation.
    Brunet JF; Dagenais D; Therrien M; Gartenberg D; Forest G
    Behav Res Methods; 2017 Aug; 49(4):1460-1469. PubMed ID: 27631990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction.
    Doty TJ; So CJ; Bergman EM; Trach SK; Ratcliffe RH; Yarnell AM; Capaldi VF; Moon JE; Balkin TJ; Quartana PJ
    Sleep; 2017 Dec; 40(12):. PubMed ID: 29029309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PC-PVT 2.0: An updated platform for psychomotor vigilance task testing, analysis, prediction, and visualization.
    Reifman J; Kumar K; Khitrov MY; Liu J; Ramakrishnan S
    J Neurosci Methods; 2018 Jul; 304():39-45. PubMed ID: 29679703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
    Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
    Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chewing versus caffeine on alertness, cognitive performance and cardiac autonomic activity during sleep deprivation.
    Kohler M; Pavy A; van den Heuvel C
    J Sleep Res; 2006 Dec; 15(4):358-68. PubMed ID: 17118092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
    Wesensten NJ; Killgore WD; Balkin TJ
    J Sleep Res; 2005 Sep; 14(3):255-66. PubMed ID: 16120100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood, alertness, and performance in response to sleep deprivation and recovery sleep in experienced shiftworkers versus non-shiftworkers.
    Wehrens SM; Hampton SM; Kerkhofs M; Skene DJ
    Chronobiol Int; 2012 Jun; 29(5):537-48. PubMed ID: 22621349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-minute smartphone-based and tablet-based psychomotor vigilance tests for the assessment of reduced alertness due to sleep deprivation.
    Grant DA; Honn KA; Layton ME; Riedy SM; Van Dongen HPA
    Behav Res Methods; 2017 Jun; 49(3):1020-1029. PubMed ID: 27325169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Behavioral Alertness in Adults with Heart Failure.
    Masterson Creber R; Pak VM; Varrasse M; Dinges DF; Wald J; Riegel B
    J Clin Sleep Med; 2016 Apr; 12(4):589-96. PubMed ID: 26715404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the unified model of performance: accuracy of group-average and individualised alertness predictions.
    Priezjev NV; Vital-Lopez FG; Reifman J
    J Sleep Res; 2023 Apr; 32(2):e13626. PubMed ID: 35521938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adaptive-duration version of the PVT accurately tracks changes in psychomotor vigilance induced by sleep restriction.
    Basner M; Dinges DF
    Sleep; 2012 Feb; 35(2):193-202. PubMed ID: 22294809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline odor identification ability predicts degradation of psychomotor vigilance during 77 hours of sleep deprivation.
    Killgore WD; McBride SA; Killgore DB; Balkin TJ; Kamimori GH
    Int J Neurosci; 2008 Sep; 118(9):1207-25. PubMed ID: 18698505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.